ORGANIZATION OF PHARMACEUTICAL CARE FOR CARDIAC RHYTHM DISORDERS
This extensive study investigates antithrombotic therapy optimization for patients with cardiac rhythm disorders (CRDs), with a specific focus on atrial fibrillation (AF), supraventricular, and ventricular arrhythmias, frequently accompanied by ischemic heart disease. Conducted from 2020 to 2023 across various cardiology departments in Uzbekistan, the study evaluated 250 patients to examine their adherence to oral anticoagulant (OAC) therapy, the potential of platelet microvesicles (PMVs) as biomarkers for thromboembolic risk, and the alignment of clinical practices with international antithrombotic guidelines.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-04-16
- DOI
- https://doi.org/10.5281/zenodo.15232161
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00